What should I Know Regarding Pregnancy, Nursing and Administering Ezallor Sprinkle 40 Mg Capsule Antihyperlipidemics Hmgco-A Reductase Inhibitors (Statins) to Children or the Elderly?
If you are PREGNANT
- Known or Theoretical Risk:
If you are NURSING
- Absolute Contraindication: MFR DOES NOT RECOMMEND DUE TO POTENTIAL ADVERSE EFFECTS IN NURSING INFANT
If you are an adult over 60
- Management or Monitoring Precaution: Musculoskeletal-Higher incidence of myopathy or rhabdomyolysis with age > 65 years and increased risk with severe renal disease. Hepatic-Monitor LFTs as liver dysfunction may increase drug exposure.
Giving Ezallor Sprinkle 40 Mg Capsule Antihyperlipidemics Hmgco-A Reductase Inhibitors (Statins) to a child under 12
- Management or Monitoring Precaution: No safety and efficacy established age < 7 years.
Selected from data included with permission and copyrighted by First Databank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except as may be authorized by the applicable terms of use.
CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.